A detailed history of Ever Source Wealth Advisors, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 100 shares of NAUT stock, worth $130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$130
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$1.67 - $2.96 $167 - $296
100 New
100 $0
Q1 2023

May 11, 2023

BUY
$1.67 - $2.77 $1,057 - $1,753
633 New
633 $1,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $162M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.